Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
718 (USA) · Dr. Nolan
consented 2013-02-17
Adverse events
Mild HYPERHIDROSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-14 (study day 57.0); relationship: POSSIBLE
Mild HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2013-04-14 (study day 57.0); relationship: POSSIBLE
Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-06 (study day 140.0); relationship: NONE
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-13 (study day 56.0); relationship: NONE
Mild SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-04-13 (study day 56.0); relationship: NONE
Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-03-06 (study day 18.0); relationship: NONE
Data queries
No data queries.